Commonly, GATA-3 expression characterizes tumors arising from skin adnexa, urothelium, salivary glands, and pancreatic ducts, whereas adenocarcinomas of lung, stomach, colon, and prostate showed positivity to a lesser extent (Miettinen et al. 2014). Here, GATA3 is linked to adenocarcinoma.